More than 1,500 AI algorithms are now FDA-cleared for medical use, over three-quarters of them in radiology alone, and some individual tools post genuinely impressive standalone accuracy numbers — but the most rigorous head-to-head studies comparing AI against doctors keep landing on the same honest answer: AI alone is not consistently more accurate than a trained radiologist, and the real advantage shows up when AI assists a doctor rather than replaces one. That distinction, assist versus replace, is where the actual 2026 evidence points, and it's more interesting than either the hype or the skepticism alone.
The Scale of Adoption Is Real
Whatever the accuracy debate, the deployment numbers aren't in question. There were 1,524 FDA-cleared AI algorithms in medicine as of March 30, 2026, and radiology accounts for 1,163 of them — 76.31% of the total, with the broader imaging-adjacent count (including cardiology and neurology tools built on imaging) pushing closer to 80%. The FDA has also accelerated its pace of clearance, now approving roughly 30 new AI algorithms per month in 2026, up from about 21 per month in 2024. Pathology, by contrast, remains far earlier in this cycle, with only 9 FDA-cleared algorithms as of the same count — a meaningful gap that shows the two fields are at very different stages of AI maturity, even though both get discussed under the same "AI diagnostics" umbrella.
Where AI Shows Genuinely Strong Standalone Numbers
Several individual tools post real, clinically validated results that are hard to dismiss. Aidoc's January 2026 body CT clearance for detecting 14 different conditions came with a 97% mean sensitivity and 98% mean specificity across those conditions. In pathology, Paige Prostate reached 0.99 sensitivity at the specimen level for detecting prostate cancer, alongside a 65.5% reduction in diagnosis time — a large enough result that Tempus AI acquired Paige outright in August 2025. For stroke care, Viz.ai's system, tested in a 474-patient multicenter trial presented at the 2025 International Stroke Conference, cut large-vessel-occlusion diagnosis time by 44%, reduced time-to-treatment by 31 minutes, and was associated with a 40% reduction in 90-day disability outcomes. Regulator-approved diabetic retinopathy screening systems, evaluated in a 2025 npj Digital Medicine meta-analysis, achieve pooled sensitivity of 93% and specificity of 90%.
But Standalone AI Alone Isn't Actually More Accurate Than Doctors
Here's where the honest picture gets more complicated than the headline numbers suggest. A prospective, multicenter study across 67 medical organizations in Moscow, analyzing 3,409 brain CT scans including 1,101 confirmed cases of intracranial hemorrhage, directly compared standalone commercial AI services against radiologists working with AI assistance. The result was decisive, and it went the opposite direction from "AI beats doctors": AI-assisted radiologists significantly outperformed standalone AI across every metric measured (p < 0.001) — sensitivity of 98.91% versus 95.91% for AI alone, specificity of 99.83% versus just 87.35% for AI alone, and overall accuracy of 99.53% versus 90.11% for AI alone. A separate hemorrhage-detection study found a similar pattern: AI showed strong sensitivity but a meaningfully higher false-positive rate (15.4%) than routine radiologist assessment (3.7%), with the researchers concluding directly that "radiologists show superior overall diagnostic accuracy" compared to AI operating alone.
The Real Answer: Collaboration Beats Either Alone
The pattern across the strongest available studies isn't "AI wins" or "doctors win" — it's that the combination reliably beats either one operating solo. Dual-reader approaches, where a case is flagged for additional review whenever the AI and the radiologist disagree, catch 11 to 15% more cancers than either the AI or the human reader working independently. That's consistent with the broader deployment pattern seen across successful AI radiology tools in 2026: narrow, well-defined clinical problems, prospective outcome data, and tight integration into existing hospital record systems that routes an AI's finding to the right clinician for confirmation, rather than AI issuing a final diagnosis on its own.
Where This Actually Deploys Today
In practice, most successful 2026 deployments look like triage acceleration rather than autonomous diagnosis. Several Level I trauma centers report AI-flagged X-rays getting read 20 to 30 minutes faster than the standard work-list order, which can genuinely matter in acute, time-sensitive care. That's the pattern across nearly every credible success story in this space: AI doesn't replace the radiologist's judgment call, it changes which cases get looked at first and flags findings a busy reader might otherwise miss on a first pass — a meaningfully different, more modest claim than "AI is more accurate than your doctor."
Standalone AI vs AI-Assisted Doctors: What the Data Shows
| Study / metric | Standalone AI | AI-assisted radiologist |
|---|---|---|
| Intracranial hemorrhage detection (Moscow, 67 sites, 3,409 scans) | Sensitivity 95.91%, specificity 87.35%, accuracy 90.11% | Sensitivity 98.91%, specificity 99.83%, accuracy 99.53% |
| Hemorrhage detection false-positive rate | 15.4% | 3.7% (routine radiologist assessment) |
| Cancer detection (dual-reader approach) | N/A — AI alone catches fewer cases | 11–15% more cancers caught than either reader alone |
Frequently Asked Questions
Is AI more accurate than radiologists at reading scans?
Not consistently on its own. Rigorous head-to-head studies, including a 67-site Moscow study on intracranial hemorrhage detection, found AI-assisted radiologists significantly outperformed standalone AI on sensitivity, specificity, and overall accuracy. Standalone AI tends to show a higher false-positive rate than routine radiologist assessment.
How many AI diagnostic tools are actually FDA-cleared?
As of March 30, 2026, there were 1,524 FDA-cleared AI algorithms in medicine, with radiology accounting for 1,163 of them, about 76% of the total. Pathology remains far earlier in adoption, with only 9 FDA-cleared algorithms as of the same count.
Does combining AI with a human doctor actually improve outcomes?
Yes, this is where the strongest evidence points. Dual-reader approaches, where disagreement between AI and a human reader triggers additional review, catch 11 to 15% more cancers than either the AI or the human reader alone.
What is AI actually used for in hospitals today?
Mostly triage and workflow acceleration rather than autonomous diagnosis. Several Level I trauma centers report AI-flagged X-rays getting read 20 to 30 minutes faster than standard order, helping route urgent findings to a radiologist for confirmation more quickly.